APH.L - Alliance Pharma plc

LSE - LSE Delayed Price. Currency in GBp
Currency in GBp

Valuation Measures

Market Cap (intraday) 5
365.25M
Enterprise Value 3
445.81M
Trailing P/E
17.15
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.81
Price/Book (mrq)
141.45
Enterprise Value/Revenue 3
3.44
Enterprise Value/EBITDA 6
12.87

Trading Information

Stock Price History

Beta (3Y Monthly) 0.79
52-Week Change 39.91%
S&P500 52-Week Change 39.71%
52 Week High 382.40
52 Week Low 359.20
50-Day Moving Average 371.20
200-Day Moving Average 373.08

Share Statistics

Avg Vol (3 month) 3853.65k
Avg Vol (10 day) 3786.83k
Shares Outstanding 5519.56M
Float 424.13M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.02
Forward Annual Dividend Yield 42.11%
Trailing Annual Dividend Rate 30.01
Trailing Annual Dividend Yield 30.02%
5 Year Average Dividend Yield 42.13
Payout Ratio 436.15%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 13, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 16.51%
Operating Margin (ttm)25.45%

Management Effectiveness

Return on Assets (ttm)5.11%
Return on Equity (ttm)8.58%

Income Statement

Revenue (ttm)129.76M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)21.20%
Gross Profit (ttm)72.65M
EBITDA 34.64M
Net Income Avi to Common (ttm)21.42M
Diluted EPS (ttm)4.10
Quarterly Earnings Growth (yoy)33.80%

Balance Sheet

Total Cash (mrq)16.47M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)94.14M
Total Debt/Equity (mrq)36.49
Current Ratio (mrq)0.64
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)27.29M
Levered Free Cash Flow (ttm)13.26M